Tags

Type your tag names separated by a space and hit enter

Epidemiology and prevention of hepatitis A in travelers.

Abstract

BACKGROUND

Hepatitis A is the second most common vaccine-preventable travel-associated infectious disease and hepatitis A virus (HAV) is the most common cause of viral hepatitis. The incidence of infection is closely related to sanitary conditions and the level of economic development.

METHODS

We evaluated HAV incidence, infection-related risk factors, and HAV vaccination rates in international travelers through retrospective analyses using major databases, such as CENTRAL, MEDLINE, EMBASE, and the current literature describing epidemiological data for HAV infection in recent years.

RESULTS AND CONCLUSIONS

We found that the incidence of HAV infection in developed countries is very low. As international travel increases, the incidence of hepatitis A among travelers remains high and likely leads to regional outbreaks. Travelers should visit the Centers for Disease Control and Prevention website or Infectious Disease Prevention Center of their countries to learn about the incidence of infectious diseases associated with their destination before going abroad to determine if they should be vaccinated.

Links

  • Publisher Full Text
  • FREE Publisher Full Text
  • Authors+Show Affiliations

    ,

    Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

    Source

    MeSH

    Disease Outbreaks
    Global Health
    Hepatitis A
    Hepatitis A Vaccines
    Hepatitis A Virus, Human
    Humans
    Travel
    Vaccination

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't
    Review

    Language

    eng

    PubMed ID

    24165384

    Citation

    Wu, Dong, and Chuan-Yong Guo. "Epidemiology and Prevention of Hepatitis a in Travelers." Journal of Travel Medicine, vol. 20, no. 6, 2013, pp. 394-9.
    Wu D, Guo CY. Epidemiology and prevention of hepatitis A in travelers. J Travel Med. 2013;20(6):394-9.
    Wu, D., & Guo, C. Y. (2013). Epidemiology and prevention of hepatitis A in travelers. Journal of Travel Medicine, 20(6), pp. 394-9. doi:10.1111/jtm.12058.
    Wu D, Guo CY. Epidemiology and Prevention of Hepatitis a in Travelers. J Travel Med. 2013;20(6):394-9. PubMed PMID: 24165384.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Epidemiology and prevention of hepatitis A in travelers. AU - Wu,Dong, AU - Guo,Chuan-Yong, Y1 - 2013/07/29/ PY - 2013/04/07/received PY - 2013/06/11/revised PY - 2013/06/14/accepted PY - 2013/10/30/entrez PY - 2013/10/30/pubmed PY - 2014/7/16/medline SP - 394 EP - 9 JF - Journal of travel medicine JO - J Travel Med VL - 20 IS - 6 N2 - BACKGROUND: Hepatitis A is the second most common vaccine-preventable travel-associated infectious disease and hepatitis A virus (HAV) is the most common cause of viral hepatitis. The incidence of infection is closely related to sanitary conditions and the level of economic development. METHODS: We evaluated HAV incidence, infection-related risk factors, and HAV vaccination rates in international travelers through retrospective analyses using major databases, such as CENTRAL, MEDLINE, EMBASE, and the current literature describing epidemiological data for HAV infection in recent years. RESULTS AND CONCLUSIONS: We found that the incidence of HAV infection in developed countries is very low. As international travel increases, the incidence of hepatitis A among travelers remains high and likely leads to regional outbreaks. Travelers should visit the Centers for Disease Control and Prevention website or Infectious Disease Prevention Center of their countries to learn about the incidence of infectious diseases associated with their destination before going abroad to determine if they should be vaccinated. SN - 1708-8305 UR - https://www.unboundmedicine.com/medline/citation/24165384/full_citation L2 - https://academic.oup.com/jtm/article-lookup/doi/10.1111/jtm.12058 DB - PRIME DP - Unbound Medicine ER -